Regeneron’s Eylea delivers positive two-year results in PANORAMA trial

This article was originally published here

The late-stage trial called PANORAMA, which features 402 patients, has been assessing Eylea in comparison to sham injection for the improvement of moderately severe to severe NPDR without

The post Regeneron’s Eylea delivers positive two-year results in PANORAMA trial appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply